 Inclusion for intratumoral injection: Subject must have 1-3 lesions amenable to HSV1716 administration by needle if superficial; by needle andor catheter if deep or pulmonary, via interventional radiology without undue risk. Lesions must meet size criteria specified in section 4.4.9. 